68 results
Page 2 of 4
8-K
EX-99.1
lfst7z839y
9 Aug 21
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:27pm
8-K
c5eg83lt
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
8-K
EX-99.1
opk46fkggv2l g03
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
8-K
EX-99.1
8w8u1j cbqgsw
25 Feb 21
Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update
8:00am
8-K
EX-99.1
b9hd va87
10 Nov 20
Gossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate Update
4:14pm
8-K
EX-99.2
lej62ft2kvwq
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
EX-99.1
mxpljvoq82ga7o8kh
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
w7u5u6
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
424B5
ctwqf
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
ixrdnc2
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
q9tei
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
wz1ckj8o1s
18 May 20
Prospectus supplement for primary offering
4:11pm